NYNanxi Yu

Nanxi Yu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nanxi Yu has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Machine Learning-Assisted Rapid Optical Imaging for Label-Free CAR T-Cell Detection in Whole Blood

    by Nanxi Yu, Ryan M. Porter, Xinyu Zhou, Wenwen Jing, Fenni Zhang, Eider F. Moreno Cortes, Paula A. Lengerke Diaz, Jose V. Forero Forero, Erica Forzani, Januario E. Castro, et al.

    Chimeric antigen receptor (CAR) T-cell therapy is an effective treatment for hematologic malignancies. However, it is limited by high costs, risk of severe toxicities such as cytokine release syndrome and neurotoxicity, and heterogeneous patient responses. The current therapy monitoring depends largely on subjective symptom assessment, routine laboratory tests, and basic vital signs, without real-time, quantitative evaluation of CAR T-cell expansion or activation in clinical practice. This lack of timely immune monitoring hampers individualized care and contributes to increased treatment costs. To address this need, we present a proof-of-concept, label-free rapid optical imaging (ROI) biosensor with automated machine learning analysis for direct quantification of CAR T-cells from whole blood. This microfluidic platform integrates red blood cell (RBC) removal, CAR T-cell capture, and imaging-based quantification on a single chip, eliminating the need for centrifugation, staining, and operator-dependent interpretation. For validation, 50 μL whole blood samples spiked with Jurkat cells expressing CD19 CARs underwent RBC depletion by agglutination and microfiltration. The remaining blood components were then incubated on a sensor chip functionalized with recombinant CD19 protein. Captured CAR T-cells were imaged by brightfield microscopy and automatically enumerated using a machine learning algorithm trained on fluorescence-validated cells. The CD-19 cells’ capture performance was validated by flow cytometry and fluorescence imaging. The trained machine learning model validated at 88% sensitivity and 96% specificity. Buffer and whole blood calibration curves were established across clinically relevant concentrations (1–1000 cells/µL) with triple replicates. The results showed high correlation (0.975 and 0.990 R2) between the spiked concentration and the detected CAR T-cells, with a 95% certainty limit of detection (LOD) and quantification (LOQ) of 0.6 and 1.1 cells/µL for spiked buffer, and 14 and 67 cells/µL for spiked whole-blood, respectively.


  • Open Access

    Machine Learning Assisted, Label-Free Rapid Optical Imaging Detection of Chimeric Antigen Receptor T-Cells in Whole Blood Samples

    by Nanxi Yu, Ryan M. Porter, Xinyu Zhou, Wenwen Jing, Fenni Zhang, Eider F. Moreno Cortes, Paula A Lengerke Diaz, Jose V Forero Forero, Erica Forzani, Januario E. Castro, et al.

    Chimeric antigen receptor (CAR) T-cell therapy is an effective treatment for hematologic malignancies. However, it is limited by high costs, risk of severe toxicities such as cytokine release syndrome and neurotoxicity, and heterogeneous patient responses. Current therapy monitoring depends largely on subjective symptom assessment, routine laboratory tests, and basic vital signs, without real-time, quantitative evaluation of CAR T-cell expansion or activation in clinical practice. This lack of timely immune monitoring hampers individualized care and contributes to increased treatment costs. To address this need, we present a proof-of-concept, label-free Rapid Optical Imaging (ROI) biosensor with automated machine learning analysis for direct quantification of functional CAR T-cells from whole blood. This microfluidic platform integrates leukocyte separation, capture, and detection on a single chip, thereby eliminating centrifugation, staining, and operator-dependent interpretation. For validation, 50 μL whole blood samples spiked with Jurkat cells expressing a CD19 CAR underwent red blood cell depletion by agglutination and microfiltration. The leukocyte-enriched fraction was then incubated on a sensor chip functionalized with recombinant CD19 protein. Captured CAR T-cells were imaged by bright-field microscopy and automatically enumerated using a machine learning algorithm. A calibration curve was established across clinically relevant concentrations (1–1,000 cells/mL), with results validated against fluorescence microscopy and flow cytometry. This ROI biosensor enables rapid, quantitative, and label-free CAR T-cell detection from whole blood without specialized equipment or infrastructure. With further development, it could provide a cost-effective point-of-care tool for real-time immune monitoring and improved clinical management of patients receiving CAR T-cell therapy.

  • Open Access

    A Microsphere-Based Sensor for Point-of-Care and Non-Invasive Acetone Detection

    by Oscar Osorio Perez, Ngan Anh Nguyen, Landon Denham, Asher Hendricks, Rodrigo E. Dominguez, Eun Ju Jeong, Marcio S. Carvalho, Mateus Lima, Jarrett Eshima, Nanxi Yu, et al.

    Ketones, which are key biomarkers of fat oxidation, are relevant for metabolic health maintenance and disease development, making continuous monitoring essential. In this study, we introduce a novel colorimetric sensor designed for potential continuous acetone detection in biological fluids. The sensor features a polydimethylsiloxane (PDMS) shell that encapsulates a sensitive and specific liquid-core acetone-sensing probe. The microsphere sensors were characterized by evaluating their size, PDMS shell thickness, colorimetric response, and sensitivity under realistic conditions, including 100% relative humidity (RH) and CO2 interference. The microsphere size and sensor sensitivity can be controlled by modifying the fabrication parameters. Critically, the sensor showed high selectivity for acetone detection, with negligible interference from CO2 concentrations up to 4%. In addition, the sensor displayed good reproducibility (CV < 5%) and stability under realistic storage conditions (over two weeks at 4 °C). Finally, the accuracy of the microsphere sensor was validated against a gold standard gas chromatography-mass spectrometry (GC-MS) method using simulated and real breath samples from healthy individuals and type 1 diabetes patients. The correlation between the microsphere sensor and GC-MS produced a linear fit with a slope of 0.948 and an adjusted R-squared value of 0.954. Therefore, the liquid-core microsphere-based sensor is a promising platform for acetone body fluid analysis.


  • Open Access

    A Microsphere-Based Sensor for Point-of-Care and Non-Invasive Acetone Detection

    by Oscar Osorio Perez, Ngan Anh Nguyen, Landon Denham, Asher Hendricks, Rodrigo Ezequiel Dominguez, Eun Ju Jeong, Marcio Carvalho, Mateus Lima, Jarrett Eshima, Nanxi Yu, et al.

    Ketones, key biomarkers of fat oxidation, are clinically relevant for metabolic health maintenance and disease development, making continuous monitoring crucial. Here, we present a novel colorimetric sensor for non-invasive, continuous acetone detection in breath and skin for point-of-care applications. The sensor comprises a polydimethylsiloxane (PDMS) shell encapsulating a highly sensitive and specific liquid-core acetone-sensing probe. Microsphere sensors were characterized by analyzing their size, PDMS shell thickness, colorimetric response, and sensitivity under realistic conditions (100% relative humidity and CO₂ interference). The microsphere size and sensor sensitivity can be controlled by modifying the fabrication parameters. Critically, the sensor showed high selectivity for acetone detection, with negligible interference from CO₂ concentrations up to 4%. Furthermore, the sensor enabled real-time, continuous, non-invasive monitoring. In addition, the sensor displayed excellent reproducibility (CV < 5%) and stability under realistic storage conditions (over two weeks at 4°C). Finally, the accuracy of the microsphere sensor was validated against a gold standard gas chromatography-mass spectrometry (GC-MS) method using simulated and real breath samples from Type 1 diabetic patients. The correlation between the microsphere sensor and GC-MS rendered a linear fit of slope equal to 0.94 and an R-squared adjustment of 0.9527. Thus, the liquid-core microsphere-based sensor offers a promising platform for continuous, non-invasive, and cost-effective acetone monitoring, potentially revolutionizing point-of-care diagnostics for metabolic disorders and health management.

  • Open Access

    A Novel Acetone Sensor for Body Fluids

    by Oscar Osorio Perez, Ngan Anh Nguyen, Asher Hendricks, Shaun Victor, Sabrina Jimena Mora, Nanxi Yu, Xiaojun Xian, Shaopeng Wang, Doina Kulick, Erica Forzani

    Ketones are well-known biomarkers of fat oxidation produced in the liver as a result of lipolysis. These biomarkers include acetoacetic acid and β-hydroxybutyric acid in the blood/urine and acetone in our breath and skin. Monitoring ketone production in the body is essential for people who use caloric intake deficit to reduce body weight or use ketogenic diets for wellness or therapeutic treatments. Current methods to monitor ketones include urine dipsticks, capillary blood monitors, and breath analyzers. However, these existing methods have certain disadvantages that preclude them from being used more widely. In this work, we introduce a novel acetone sensor device that can detect acetone levels in breath and overcome the drawbacks of existing sensing approaches. The critical element of the device is a robust sensor with the capability to measure acetone using a complementary metal oxide semiconductor (CMOS) chip and convenient data analysis from a red, green, and blue deconvolution imaging approach. The acetone sensor device demonstrated sensitivity of detection in the micromolar-concentration range, selectivity for detection of acetone in breath, and a lifetime stability of at least one month. The sensor device utility was probed with real tests on breath samples using an established blood ketone reference method.